Evidence map›Paper›PMID 24999380›Full record

ArticleMolecular autism2014

Genetic analysis of GABRB3 as a candidate gene of autism spectrum disorders.

Chia-Hsiang Chen, Chia-Chun Huang, Min-Chih Cheng, Yen-Nan Chiu, Wen-Che Tsai, Yu-Yu Wu, Shih-Kai Liu, Susan Shur-Fen Gau

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Molecular autism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00494754 (Clinical and Genetic Study of Autism Spectrum Disorder), which is not on this map. Cited by 37 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 3 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00494754 completednot on this map

Clinical and Genetic Study of Autism Spectrum Disorder

TypeobservationalSponsorNational Taiwan University HospitalRan2007 to 2011Enrolled300ConditionsAutism
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 3 syntheses or guidelines pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. GABAergic Inhibition Gates Perceptual Awareness During Binocular Rivalry.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Trial
  6. Trial
  7. Drug Repurposing for Treating NCOR-Related Intellectual Disability.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  8. Role of GABAMolecular biology reports · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Chia-Hsiang ChenDepartment of Psychiatry, Chang Gung Memorial Hospital-Linkou, Taoyuan, Taiwan ; Department and Graduate Institute of Biomedical Sciences, Chang Gung University, Taoyuan, Taiwan ; Department of Psychiatry, National Taiwan University Hospital and College of Medicine, 7, Chung-Shan South Road, Taipei 10002, Taiwan.
Chia-Chun HuangInstitute of Medical Sciences, Tzu Chi University, Hualien, Taiwan.
Min-Chih ChengDepartment of Psychiatry, Yuli Mental Health Research Center, Yuli Veterans Hospital, Hualien, Taiwan.
Yen-Nan ChiuDepartment of Psychiatry, National Taiwan University Hospital and College of Medicine, 7, Chung-Shan South Road, Taipei 10002, Taiwan.
Wen-Che TsaiDepartment of Psychiatry, National Taiwan University Hospital and College of Medicine, 7, Chung-Shan South Road, Taipei 10002, Taiwan.
Yu-Yu WuDepartment of Psychiatry, Chang Gung Memorial Hospital-Linkou, Taoyuan, Taiwan.
Shih-Kai LiuDepartment of Child and Adolescent Psychiatry, Taoyaun Psychiatric Center, Ministry of Health and Welfare, Taoyuan, Taiwan.
Susan Shur-Fen GauDepartment of Psychiatry, National Taiwan University Hospital and College of Medicine, 7, Chung-Shan South Road, Taipei 10002, Taiwan ; Graduate Institute of Brain and Mind Sciences, and Graduate Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan.
Chang Gung Memorial Hospital · TWNational Taiwan University Hospital · TWMinistry of Health and Welfare · TWNational Taiwan University · TWTzu Chi University · TWYuli Veterans Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGABRB3 is a position candidate gene at chromosome 15q12 that has been implicated in the neurobiology of autism spectrum disorders (ASD). The aim of this study was to examine the genetic association of GABRB3 with ASD.

methodsThe sample consisted of 356 patients with clinical diagnosis of ASD according to the DSM-IV diagnostic criteria and confirmed by the Autism Diagnostic Interview-Revised and 386 unrelated controls. We searched for mutations at all the exonic regions and 1.6 Kb of the 5' region of GABRB3 in the genomic DNA of all the participants using the Sanger sequencing. We implemented a case-control association analysis of variants detected in this sample, and conducted a reporter gene assay to assess the functional impact of variants at the 5' regulatory region.

resultsWe detected six known common SNPs; however, they were not associated with ASD. Besides, a total of 22 rare variants (12 at 5' regulatory, 4 at intronic, and 6 at exonic regions) were detected in 18 patients and 6 controls. The frequency of rare variants was significantly higher in the patient group than in the control group (18/356 versus 6/386, odds ratio = 3.37, P = 0.007). All the 12 rare variants at the 5' regulatory region were only detected in 7 patients, but not in any of the controls (7/356 versus 0/386, Fisher's exact test, P = 0.006). Two patients carried multiple rare variants. Family studies showed that most of these rare variants were transmitted from their parents. Reporter gene assays revealed that four rare variants at the 5' regulatory region and 1 at exon 1a untranslated region had elevated reporter gene activities compared to two wild type alleles.

conclusionsOur data suggest rare variants of GABRB3 might be associated with ASD, and increased GABRB3 expression may contribute to the pathogenesis of ASD in some patients.

trial registrationCLINICAL TRIAL REGISTRATION IDENTIFIER: NCT00494754.

Indexed as

Autism spectrum disordersCase-control associationGABRB3GeneticsRare variants

Identifiers

PMID24999380
PMCPMC4082499
OpenAlexW2158651733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.